Research Topics
Species | Alfred CheungSummaryAffiliation: University of Utah Country: USA Publications
Research Grants
| Collaborators
|
Detail Information
Publications
Modelling ultrasound-induced mild hyperthermia of hyperplasia in vascular graftsMark R Brinton
Department of Electrical and Computer Engineering, University of Utah, Salt Lake City, USA
Theor Biol Med Model 8:42. 2011..The goal was to determine whether ultrasound exposure of an ePTFE graft can generate temperatures sufficient to prevent cell growth on the graft without damaging nearby soft tissues and blood...
Atherosclerotic cardiovascular disease risks in chronic hemodialysis patientsA K Cheung
National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD, USA
Kidney Int 58:353-62. 2000..Cardiovascular diseases are the most common causes of death among chronic hemodialysis patients, yet the risk factors for these events have not been well established...
Association between serum 2-microglobulin level and infectious mortality in hemodialysis patientsAlfred K Cheung
Medical Service, University of Utah, Salt Lake City, UT 84112, USA
Clin J Am Soc Nephrol 3:69-77. 2008....
Pathogenesis and local drug delivery for prevention of vascular access stenosisAlfred K Cheung
Veterans Affair Salt Lake City Healthcare System, Salt Lake City, Utah, USA
J Ren Nutr 18:140-5. 2008..Because of the chronic nature of the stimuli, strategies that allow for the ready replenishment of the drug depot are preferable and are currently under development...
Cardiac diseases in maintenance hemodialysis patients: results of the HEMO StudyAlfred K Cheung
Veterans Affairs Salt Lake City Healthcare System and University of Utah, Salt Lake City, 84112, USA
Kidney Int 65:2380-9. 2004....
Effects of high-flux hemodialysis on clinical outcomes: results of the HEMO studyAlfred K Cheung
Veterans Affairs Salt Lake City Healthcare System and Department of Medicine, University of Utah, Salt Lake City, Utah 84112, USA
J Am Soc Nephrol 14:3251-63. 2003..The subgroup results that demonstrate that patients with different durations of dialysis are affected differently by high-flux dialysis are interesting and require further study for confirmation...
Serum beta-2 microglobulin levels predict mortality in dialysis patients: results of the HEMO studyAlfred K Cheung
VA Salt Lake City Healthcare System and Department of Medicine, University of Utah, Salt Lake City, Utah 84112, USA
J Am Soc Nephrol 17:546-55. 2006..05 to 1.19; P = 0.001), after adjustment for residual kidney urea clearance and number of prestudy years on dialysis. This association is supportive of the potential value of beta(2)M as a marker to guide chronic hemodialysis therapy...
Seasonal variations in clinical and laboratory variables among chronic hemodialysis patientsAlfred K Cheung
National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland, USA
J Am Soc Nephrol 13:2345-52. 2002..In addition, awareness of these variations might facilitate the interpretation of laboratory results and the clinical treatment of these patients...
Is lipid control necessary in hemodialysis patients?Alfred K Cheung
Medical Service, Veterans Affairs Salt Lake City Healthcare System and Division of Nephrology and Hypertension and Dialysis Program, University of Utah, Salt Lake City, Utah, USA
Clin J Am Soc Nephrol 4:S95-101. 2009..More research efforts should be directed toward these dyslipidemic states and the multitude of other putative cardiovascular risk factors in dialysis patients...
Association of obesity with inflammation in chronic kidney disease: a cross-sectional studyNirupama Ramkumar
Division of Nephrology and Hypertension, Department of Pathology, University of Utah School of Medicine, Salt Lake City, Utah, USA
J Ren Nutr 14:201-7. 2004..CONCLUSION: These data suggest that as in the general population, in CKD patients, obesity, a traditional risk factor for atherosclerosis, is associated with inflammation, a novel risk factor for atherosclerosis...
Perivascular tissue pharmacokinetics of dipyridamoleKosalaram Goteti
Department of Pharmaceutics and Pharmaceutical Chemistry, University of Utah, 421 Wakara Way, 318, Salt Lake City, Utah 84108, USA
Pharm Res 23:718-28. 2006..The pharmacokinetic parameters and resulting computational simulations are helpful in exploring perivascular drug delivery strategies...
Lack of synergistic effects of metabolic syndrome and plasma fibrinogen on coronary events and mortality in moderate CKDNirupama Ramkumar
Division of Nephrology and Hypertension, University of Utah School of Medicine, Salt Lake City, UT, USA
Am J Kidney Dis 49:356-64. 2007..Metabolic syndrome and inflammation are interlinked in patients with moderate chronic kidney disease (CKD)...
Expression of C-reactive protein in myointimal hyperplasia in a porcine arteriovenous graft modelTadashi Kuji
Department of Medicine, University of Utah and Medical Services, Veterans Affairs Salt Lake City Healthcare System, UT 84112, USA
Nephrol Dial Transplant 22:2469-75. 2007....
The association of lipid-modifying medications with mortality in patients on long-term peritoneal dialysisAlexander S Goldfarb-Rumyantzev
Division of Nephrology and Hypertension, University of Utah School of Medicine, Salt Lake City, UT, USA
Am J Kidney Dis 50:791-802. 2007..The effect of lipid-lowering therapy on clinical outcomes in peritoneal dialysis patients has not been carefully addressed...
Neointimal hyperplasia associated with synthetic hemodialysis graftsLi Li
Department of Medicine, University of Utah, Salt Lake City, Utah, USA
Kidney Int 74:1247-61. 2008..Successful prevention of graft stenosis would provide a superior alternative to the native fistula as hemodialysis vascular access...
Inhibition of neointimal hyperplasia in vascular grafts by sustained perivascular delivery of paclitaxelTakahisa Masaki
Departments of Medicine, Bioengineering, Pathology, Pharmaceutics, and Surgery, and Animal Resource Center, University of Utah, Salt Lake City, Utah, USA
Kidney Int 66:2061-9. 2004....
Cellular and morphological changes during neointimal hyperplasia development in a porcine arteriovenous graft modelLi Li
Department of Medicine, University of Utah, Salt Lake City, UT 84112, USA
Nephrol Dial Transplant 22:3139-46. 2007..The nature of the proliferating cells in these lesions is not well understood. A better understanding of the cells contributing to NH is important to the development of preventive strategies...
Correlation of tissue drug concentrations with in vivo magnetic resonance images of polymer drug depot around arteriovenous graftShawn C Owen
Department of Pharmaceutics and Pharmaceutical Chemistry, College of Pharmacy, 301 Skaggs Hall, 30 South 2000 East, Salt Lake City, UT 84112, USA
J Control Release 146:23-30. 2010..In addition, MRI is useful for the monitoring of the location of the drug depot...
A population-based assessment of the familial component of chronic kidney disease mortalityAlexander S Goldfarb-Rumyantzev
Division of Nephrology and Hypertension and Department of Family and Preventive Medicine, University of Utah School of Medicine, Salt Lake City, Utah 84112, USA
Am J Nephrol 26:142-8. 2006..This is the first population-based analysis of the familial component of ESRD and non-ESRD CKD...
Cellular pharmacokinetics and pharmacodynamics of dipyridamole in vascular smooth muscle cellsWeiwei Zhu
Department of Pharmaceutics and Pharmaceutical Chemistry, University of Utah, Salt Lake City, UT 84108, USA
Biochem Pharmacol 72:956-64. 2006....
Evaluation of histological techniques for quantifying haemodialysis arteriovenous (AV) graft hyperplasiaChristi M Terry
Department of Medicine, University of Utah and Medical Service, Veterans Affairs Salt Lake City Health Care System, Salt Lake City, UT 84112 5350, USA
Nephrol Dial Transplant 21:3172-9. 2006..We identified sources of variability in three histological methods for assessing hyperplasia in a porcine AV graft model...
Kinetics of urea and beta-microglobulin during and after short hemodialysis treatmentsJohn K Leypoldt
VA Salt Lake City Health Care System, Salt Lake City, Utah, USA
Kidney Int 66:1669-76. 2004....
The association of lipid levels with mortality in patients on chronic peritoneal dialysisArsalan N Habib
Dialysis Program, University of Utah School of Medicine, 30 North Medical Drive, Salt Lake City, UT 84132, USA
Nephrol Dial Transplant 21:2881-92. 2006..The present study evaluated the association of serum TC and triglycerides with clinical outcomes in chronic peritoneal dialysis (PD) patients...
Familiality of cardiovascular mortality in end-stage renal disease patientsNatalie Naiman
Department of Biomedical Informatics, University of Utah School of Medicine, Salt Lake City, Utah, USA
Am J Nephrol 29:237-43. 2009..24, 95% CI 1.01-1.49). In conclusion, this study suggests that, in addition to many putative risk factors, the increased risk of CV death in ESRD patients may have a familial contribution...
Using the stochastic collocation method for the uncertainty quantification of drug concentration due to depot shape variabilityJ Samuel Preston
Scientific Computing and Imaging Institute and the School of Computing, University of Utah, Salt Lake City, UT 84112, USA
IEEE Trans Biomed Eng 56:609-20. 2009..We demonstrate that once the underlying stochastic process is characterized, quantification of the introduced variability is quite straightforward and provides an important step in the validation and verification process...
Inflammation and inverse associations of body mass index and serum creatinine with mortality in hemodialysis patientsSrinivasan Beddhu
Veterans Affairs Salt Lake City Healthcare System, Salt Lake City, Utah 84112, USA
J Ren Nutr 17:372-80. 2007..Protein-energy wasting and inflammation are common and associated with an increased risk of mortality in hemodialysis (HD) patients. We examined the extent to which they mediate the associations of each other with death in this population...
PDGF-induced proliferation in human arterial and venous smooth muscle cells: molecular basis for differential effects of PDGF isoformsLi Li
Division of Nephrology and Hypertension, University of Utah, Salt Lake City, UT, USA
J Cell Biochem 112:289-98. 2011..These results may provide an explanation for the differential susceptibility to proliferative vascular diseases of arteries and veins...
Misoprostol effects on diclofenac-induced cardiorenal changes in salt-sensitive patients with hypertension: the MEDIC StudyMark A Munger
Department of Pharmacotherapy, College of Pharmacy, University of Utah, Salt Lake City, Utah 84112 5820, USA
Pharmacotherapy 28:834-42. 2008..To determine whether coadministration of misoprostol with the nonsteroidal antiinflammatory drug diclofenac lessens the increase in blood pressure and improves the alterations in renal hemodynamics induced by diclofenac...
Longitudinal assessment of hyperplasia using magnetic resonance imaging without contrast in a porcine arteriovenous graft modelChristi M Terry
Department of Medicine, Division of Nephrology and Hypertension, University of Utah, Salt Lake City, UT 84112, USA
Acad Radiol 16:96-107. 2009..The authors report the use of magnetic resonance (MR) imaging (MRI) without contrast agent to monitor tissue hyperplasia formation as well as luminal area in a porcine model of AV graft stenosis...
Serum alkaline phosphatase and mortality in African Americans with chronic kidney diseaseSrinivasan Beddhu
Veterans Affairs Salt Lake City Healthcare System, Salt Lake City, Utah, USA
Clin J Am Soc Nephrol 4:1805-10. 2009....
Relationship between volume status and blood pressure during chronic hemodialysisJohn K Leypoldt
University of Utah, Salt Lake City, Utah 84112 5350, USA
Kidney Int 61:266-75. 2002..Specifically, the effect of interdialytic fluid accumulation (or intradialytic fluid removal) on BP is controversial...
In vitro pharmacological inhibition of human vascular smooth muscle cell proliferation for the prevention of hemodialysis vascular access stenosisTakahisa Masaki
Division of Nephrology and Hypertension, University of Utah School of Medicine, Salt Lake City, Utah, USA
Blood Purif 22:307-12. 2004..Quiescent cells were cultured in the presence of growth factors, fetal bovine serum and incremental concentrations of the test drug. Cell proliferation was assessed by the MTT reduction assay...
Duration of end-stage renal disease and kidney transplant outcomeAlex Goldfarb-Rumyantzev
University of Utah Health School of Medicine, Salt Lake City, UT, USA
Nephrol Dial Transplant 20:167-75. 2005..The goal of the study was to characterize the relationship between the duration of dialysis vs allograft and patient survival...
Impact of timing of initiation of dialysis on mortalitySrinivasan Beddhu
Renal Section, Salt Lake VA Healthcare System, Division of Nephrology and Hypertension, and Division of Clinical Epidemiology, University of Utah School of Medicine, Salt Lake City, Utah 84112, USA
J Am Soc Nephrol 14:2305-12. 2003..Furthermore, these data do not support earlier initiation of dialysis. Therefore, for patients without clinical indications for initiation of dialysis, the appropriate GFR level for initiation of dialysis is unknown...
Creatinine production, nutrition, and glomerular filtration rate estimationSrinivasan Beddhu
Renal Section, Salt Lake VA Healthcare System, Salt Lake City, Utah, USA
J Am Soc Nephrol 14:1000-5. 2003..The fundamental assumption of the MDRD formula is invalid in patients with advanced renal failure, and the use of this formula in these patients might introduce biases...
The association between BP and mortality in patients on chronic peritoneal dialysisAlexander S Goldfarb-Rumyantzev
Division of Nephrology and Hypertension, University of Utah School of Medicine, 85 North Medical Drive, East Rm 201, Salt Lake City, UT 84112 5350, USA
Nephrol Dial Transplant 20:1693-701. 2005..It is not clear if this is the consequence of uraemia or related to the dialysis type. The goal of this project was to identify the relationship between BP and mortality in patients on chronic peritoneal dialysis (PD)...
The role of pre-emptive re-transplant in graft and recipient outcomeAlexander S Goldfarb-Rumyantzev
Division of Nephrology, University of Utah Health School of Medicine, Salt Lake City, UT 84112, USA
Nephrol Dial Transplant 21:1355-64. 2006..The effect of the pre-emptive re-transplant, and of inter-transplant waiting time generally, on graft and recipient survival is not well established...
Computer simulation of small-solute and middle-molecule removal during short daily and long thrice-weekly hemodialysisAlexander S Goldfarb-Rumyantzev
Division of Nephrology and Hypertension, University of Utah, School of Medicine, and VA Salt Lake City Health Care System, Salt Lake City, UT 84112, USA
Am J Kidney Dis 40:1211-8. 2002..More intensive hemodialysis (HD) regimens (short daily and long thrice-weekly HD) provide potential opportunities for improved patient outcome. An adequate dialysis dose for these regimens cannot be established from the existing literature...
Impact of renal failure on the risk of myocardial infarction and deathSrinivasan Beddhu
Renal Section, Salt Lake VA Healthcare System, Salt Lake City, Utah, USA
Kidney Int 62:1776-83. 2002..We examined whether renal failure independently increases the risk of myocardial infarction and death...
Associations of metabolic syndrome with inflammation in CKD: results From the Third National Health and Nutrition Examination Survey (NHANES III)Srinivasan Beddhu
Medical Service, Salt Lake Veterans Affairs Healthcare System, Salt Lake City, UT, USA
Am J Kidney Dis 46:577-86. 2005..Although metabolic syndrome is associated with inflammation in the general population, it is unknown whether similar associations exist in patients with chronic kidney disease...
The role of pretransplantation renal replacement therapy modality in kidney allograft and recipient survivalAlexander S Goldfarb-Rumyantzev
University of Utah School of Medicine, Salt Lake City, UT, USA
Am J Kidney Dis 46:537-49. 2005..The effect of pretransplantation renal replacement therapy (RRT) modality on allograft and recipient survival outcome is not well understood...
Association of serum albumin and atherosclerosis in chronic hemodialysis patientsSrinivasan Beddhu
National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, USA
Am J Kidney Dis 40:721-7. 2002..Because cardiovascular disease is the leading cause of death and hypoalbuminemia predicts mortality, hypoalbuminemia may be associated with atherosclerosis...
A crossover study of short daily haemodialysisAlexander S Goldfarb-Rumyantzev
University of Utah School of Medicine, and Veterans Affairs Salt Lake City 84112, USA
Nephrol Dial Transplant 21:166-75. 2006..Most of these previous studies however have not been performed with rigorous controls...
Dialyzer membranes as determinants of the adequacy of dialysisMadhukar Chelamcharla
Department of Medicine, University of Utah School of Medicine, Salt Lake City, UT 84112, USA
Semin Nephrol 25:81-9. 2005..Novel designs of dialyzers include the optimization of fluid flow path geometry and increasing the membrane pore selectivity for solutes by using nanotechnology...
Mechanism of dipyridamole's action in inhibition of venous and arterial smooth muscle cell proliferationSergey B Zhuplatov
Veterans Affairs Salt Lake City Healthcare System, Departments of Medicine, Pharmacology and Toxicology, and Biochemistry, University of Utah, Salt Lake City, Utah, USA
Basic Clin Pharmacol Toxicol 99:431-9. 2006....
Revisiting the hemodialysis doseJohn K Leypoldt
Dialysis Program, University of Utah, Salt Lake City, Utah 84112 5350, USA
Semin Dial 19:96-101. 2006..solutes be dependent on gender? 4) Should the dialysis dose for middle molecules be used in clinical practice? 5) What should be the dialysis dose when using hemodialysis treatment strategies that are more frequent than thrice weekly?..
Arterial and venous smooth-muscle cells differ in their responses to antiproliferative drugsSeung-Jung Kim
Divsion of Nephrology, Ewha Women's University, Salt Lake City, UT 84112, USA
J Lab Clin Med 144:156-62. 2004....
Patient preferences for in-center intense hemodialysisNirupama Ramkumar
Division of Nephrology and Hypertension, University of Utah School of Medicine, Salt Lake City, Utah 84112, USA
Hemodial Int 9:281-95. 2005..Disruption of personal time, however, is an important consideration. Success of DHD program would depend on arrangements for transportation to dialysis unit...
Development of a sustained-release system for perivascular delivery of dipyridamoleWeiwei Zhu
Department of Pharmaceutics and Pharmaceutical Chemistry, University of Utah, Salt Lake City, 84108, USA
J Biomed Mater Res B Appl Biomater 77:135-43. 2006..In vivo release of dipyridamole from microspheres/ReGel exhibited a comparable release pattern to that seen in vitro. This injectable platform is a promising technique for sustained perivascular delivery of antiproliferative drugs...
Dialyzer performance in the HEMO Study: in vivo K0A and true blood flow determined from a model of cross-dialyzer urea extractionThomas A Depner
Hemodialysis HEMO Study Group, National Institutes of Health, Bethesda, MD, USA
ASAIO J 50:85-93. 2004....
Different signaling responses to anti-proliferative agents in human aortic and venous smooth muscle cellsRay M Lee
Department of Internal Medicine, University of Utah, Salt Lake City, Utah, USA
J Cell Biochem 99:835-44. 2006..In contrast, p38 MAPK is an important pro-survival regulator in VSMCs and p42/44 MAPK appears to play a minor role in responding to anti-proliferative drugs...
Differential effects of imatinib on PDGF-induced proliferation and PDGF receptor signaling in human arterial and venous smooth muscle cellsLi Li
Department of Medicine, University of Utah, 85 North Medical Drive East, Salt Lake City, UT 84112, USA
J Cell Biochem 99:1553-63. 2006..These data highlight inherent pharmacodynamic differences between VSMC and ASMC in receptor and cell signaling functions and suggest that imatinib therapy may be useful for the prevention of venous stenosis in vascular grafts...
Elevated fibrinogen fragment levels in uremic plasma inhibit platelet function and expression of glycoprotein IIb-IIIaUsha R Thekkedath
Research and Medical Service, George E. Wahlen Department of Veterans Afairs Medical Center, and University of Utah School of Medicine; Salt Lake City, UT 84148, USA
Am J Hematol 81:915-26. 2006..The decrease in plasma levels of FF > 100 kDa following HD suggests that adsorption to the dialysis membrane contributes to their removal...
Disordered mineral metabolism in hemodialysis patients: an analysis of cumulative effects in the Hemodialysis (HEMO) StudyRon Wald
Division of Nephrology and The Keenan Research Centre in the Li Ka Shing Knowledge Institute of St Michael s Hospital, Toronto, Ontario, Canada
Am J Kidney Dis 52:531-40. 2008..Although the values of these markers often evolve over time, no study has examined the accumulated effects of these abnormalities on important clinical end points...
Effect of dialysis dose and membrane flux in maintenance hemodialysisGarabed Eknoyan
Baylor College of Medicine, Houston, USA
N Engl J Med 347:2010-9. 2002..CONCLUSIONS: Patients undergoing hemodialysis thrice weekly appear to have no major benefit from a higher dialysis dose than that recommended by current U.S. guidelines or from the use of a high-flux membrane...
Hollow fiber shape alters solute clearances in high flux hemodialyzersJohn K Leypoldt
Research Service, VA Salt Lake City Health Care System, UT, USA
ASAIO J 49:81-7. 2003..We conclude that the mass transfer characteristics of high flux dialyzers can be altered by the shape of the hollow fibers...
Hemodialysis vascular access dysfunction: a cellular and molecular viewpointPrabir Roy-Chaudhury
Division of Nephrology, MSB G 251, University of Cincinnati, 231 Albert Sabin Way, Cincinnati, OH 45267 0585
J Am Soc Nephrol 17:1112-27. 2006....
Does statin therapy improve cardiovascular outcomes in patients with type 2 diabetes receiving hemodialysis?Bonnie C H Kwan
Prince of Wales Hospital, Hong Kong
Nat Clin Pract Nephrol 2:76-7. 2006
Risk factors for sudden cardiac death in patients with chronic renal insufficiency and left ventricular dysfunctionMichel Chonchol
Division of Renal Diseases and Hypertension, University of Colorado Health Sciences Center, Denver, Colo 80262, USA
Am J Nephrol 27:7-14. 2007..It is, however, unclear if the risk and risk factors of SCD in these patients is modulated by the coexistence of mild chronic renal insufficiency...
Lipoprotein metabolism and lipid management in chronic kidney diseaseBonnie C H Kwan
Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong, China
J Am Soc Nephrol 18:1246-61. 2007
The HEMO Study: applicability and generalizabilityMichael V Rocco
Wake Forest University School of Medicine, Department of Internal Medicine/Nephrology, Medical Center Boulevard, Winston-Salem, NC 27157-1053, USA
Nephrol Dial Transplant 20:278-84. 2005
Improving outcomes in CKD and ESRD patients: carrying the torch from training to practiceAllen R Nissenson
Department of Medicine, Division of Nephrology, David Geffen School of Medicine, UCLA, Los Angeles, California 90095, USA
Semin Dial 17:380-97. 2004..If nephrologists are to take their appropriate place as leaders of the care delivery team, nephrology fellowships must be restructured with appropriate emphasis placed on the comprehensive care of ESRD and CKD patients...
Cerebrovascular disease in maintenance hemodialysis patients: results of the HEMO StudyJames A Delmez
Washington University, St Louis, MO, USA
Am J Kidney Dis 47:131-8. 2006....
Different responses by cultured aortic and venous smooth muscle cells to gamma radiationSeung-Jung Kim
Division of Nephrology, Ewha Women's University, Seoul, Korea
Kidney Int 68:371-7. 2005..CONCLUSION: Inasmuch as myointimal hyperplasia occurs at both arterial and venous anastomoses, future strategies using radiation to prevent hemodialysis vascular access stenosis should take these differences into consideration...
The career of Lee W. HendersonJonas Bergstrom
Karolinska Institute, Huddinge, Sweden
J Am Soc Nephrol 13:S1-2. 2002
Research Grants
- PREVENTION OF HEMODIALYSIS VASCULAR ACCESS STENOSISAlfred Cheung; Fiscal Year: 2004..Furthermore, the results will provide the basis for local delivery of drugs and proteins of interest to a variety of tissues. ..
- PREVENTION OF HEMODIALYSIS VASCULAR ACCESS STENOSISAlfred Cheung; Fiscal Year: 2007..It is highly likely that, within this 5-year proposal, the results of this project can be applied to pilot clinical studies. ..
- PREVENTION OF HEMODIALYSIS VASCULAR ACCESS STENOSISAlfred Cheung; Fiscal Year: 2009..It is highly likely that, within this 5-year proposal, the results of this project can be applied to pilot clinical studies. ..
- PREVENTION OF HEMODIALYSIS VASCULAR ACCESS STENOSISAlfred K Cheung; Fiscal Year: 2010..It is highly likely that, within this 5-year proposal, the results of this project can be applied to pilot clinical studies. ..
